622
Views
0
CrossRef citations to date
0
Altmetric
HPV

Awareness regarding human papillomavirus and willingness for vaccination among college students with or without medical background in Guizhou Province

, , , , , , , , & show all
Article: 2295992 | Received 04 Sep 2023, Accepted 13 Dec 2023, Published online: 08 Jan 2024

References

  • Harden ME, Munger K. Human papillomavirus molecular biology. Mutat Res Rev Mutat Res. 2017;772:3–9. doi:10.1016/j.mrrev.2016.07.002.
  • Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007;370(9590):890–907. doi:10.1016/S0140-6736(07)61416-0.
  • Yousefi Z, Aria H, Ghaedrahmati F, Bakhtiari T, Azizi M, Bastan R, Hosseini R, Eskandari N. An update on human papilloma virus vaccines: history, types, protection, and efficacy. Front Immunol. 2021;12:805695. doi:10.3389/fimmu.2021.805695.
  • Shen X, Cheng Y, Ren F, Shi Z. The burden of cervical cancer in China. Front Oncol. 2022;12:979809. doi:10.3389/fonc.2022.979809.
  • Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, Arbyn M, Basu P, Bray F, Vaccarella S. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global cervical cancer elimination initiative. Lancet Glob Health. 2023;11:e197–206. doi:10.1016/S2214-109X(22)00501-0.
  • Tota JE, Giuliano AR, Goldstone SE, Dubin B, Saah A, Luxembourg A, Velicer C, Palefsky JM. Anogenital Human Papillomavirus (HPV) infection, seroprevalence, and risk factors for HPV seropositivity among sexually active men enrolled in a global HPV vaccine trial. Clin Infect Dis. 2022;74:1247–56. doi:10.1093/cid/ciab603.
  • Shimabukuro TT, Su JR, Marquez PL, Mba-Jonas A, Arana JE, Cano MV. Safety of the 9-valent human papillomavirus vaccine. Pediatrics. 2019;144:e20191791. doi:10.1542/peds.2019-1791.
  • Pils S, Joura EA. From the monovalent to the nine-valent HPV vaccine. Clin Microbiol Infect. 2015;21:827–33. doi:10.1016/j.cmi.2015.05.001.
  • Giuliano AR, Palefsky JM, Goldstone S, Moreira ED, Penny ME, Aranda C, Vardas E, Moi H, Jessen H, Hillman R, et al. Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. N Engl J Med. 2011;364:401–11. doi:10.1056/NEJMoa0909537.
  • Ring LL, Munk C, Galanakis M, Tota JE, Thomsen LT, Kjaer SK. Incidence of cervical precancerous lesions and cervical cancer in Denmark from 2000 to 2019: population impact of multi-cohort vaccination against human papillomavirus infection. Int J Cancer. 2023;152:1320–7. doi:10.1002/ijc.34328.
  • Zhang X, Shi J, Zhang Y, Yu W. Awareness and coverage of human papillomavirus vaccine among female university students in 2019. Chin J Vaccines Immun. 2021;27:458–61+467.
  • Chen H, Zhou J, Huang Q, Si M-Y, Su X-Y, Li J. Status of human papillomavirus vaccination and knowledge, attitudes, and influencing factors towards human papillomavirus and its vaccines among university students in Western China. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2021;43(4):545–50. doi:10.3881/j.issn.1000-503X.13153.
  • Chen G, Wu B, Dai X, Zhang M, Liu Y, Huang H, Mei K, Wu Z. Gender differences in knowledge and attitude towards HPV and HPV vaccine among college students in Wenzhou, China. Vaccines. 2021;10:10. doi:10.3390/vaccines10010010.
  • Xin HN, Li HJ, Li Z, Li XW, Li MF, Zhang HR, Feng BX, Lun WH, Yan HW, Long J, et al. Genital HPV infection among heterosexual and homosexual male attendees of sexually transmitted diseases clinic in Beijing, China. Epidemiol Infect. 2017;145:2838–47. doi:10.1017/S0950268817001698.
  • Jiang L, Tian X, Peng D, Zhang L, Xie F, Bi C, Wang R, Wang J, Qi D. HPV prevalence and genotype distribution among women in Shandong Province, China: analysis of 94,489 HPV genotyping results from Shandong’s largest independent pathology laboratory. PLoS One [Internet]. 2019 [accessed 2023 Aug 27];14:e0210311. https://pubmed.ncbi.nlm.nih.gov/30653566/.
  • Zhang F, Li M, Li X, Bai H, Gao J, Liu H. Knowledge of cervical cancer prevention and treatment, and willingness to receive HPV vaccination among college students in China. BMC Public Health. 2022;22:2269. doi:10.1186/s12889-022-14718-0.
  • Liu Y, Di N, Tao X. Knowledge, practice and attitude towards HPV vaccination among college students in Beijing, China. Hum Vaccines Immunother. 2020;16:116–23. doi:10.1080/21645515.2019.1638727.
  • Waller J, Ostini R, Marlow LAV, McCaffery K, Zimet G. Validation of a measure of knowledge about human papillomavirus (HPV) using item response theory and classical test theory. Prev Med. 2013;56:35–40. doi:10.1016/j.ypmed.2012.10.028.
  • Dai Z, Si M, Su X, Wang W, Zhang X, Gu X, Ma L, Li J, Zhang S, Ren Z, et al. Willingness to human papillomavirus (HPV) vaccination and influencing factors among male and female university students in China. J Med Virol. 2022;94:2776–86. doi:10.1002/jmv.27478.
  • Yang B, Shuqi W, Yang R, Jie Z, Guowei H, Yaomei M, Zhuoyu S. A survey of knowledge of HPV and willingness to inoculate vaccination among medical student. Chin Mater Child Health Study. 2020;31:1635–40.
  • Zhang J, Zhang J, Yang J, Chen X, Dong X. Investigation on acceptance of HPV vaccination and its determinants among college students in Guangzhou city. Chin J Dise Control. 2018;22:965–7+971.
  • Berenson AB, Hirth JM, Fuchs EL. Multidisciplinary translation team on reproductive women’s Health. US medical students’ willingness to offer the HPV vaccine by vaccination status. Vaccine. 2017;35:1212–15. doi:10.1016/j.vaccine.2017.01.028.
  • Du EY, Adjei Boakye E, Taylor DB, Kuziez D, Rohde RL, Pannu JS, Simpson MC, Patterson RH, Varvares MA, Osazuwa-Peters N. Medical students’ knowledge of HPV, HPV vaccine, and HPV-associated head and neck cancer. Hum Vaccines Immunother. 2022;18:2109892. doi:10.1080/21645515.2022.2109892.
  • Hu S, Hu X, Xu J, Li L, Du L, Jia Y, Zhu L. A survey on the cognition of HPV and its vaccine among female college students. Chin Res Matern Child Health. 2022;33:75–81.
  • Dillner J, Nygård M, Munk C, Hortlund M, Hansen BT, Lagheden C, Liaw K-L, Kjaer SK. Decline of HPV infections in Scandinavian cervical screening populations after introduction of HPV vaccination programs. Vaccine. 2018;36:3820–9. doi:10.1016/j.vaccine.2018.05.019.
  • Mesher D, Panwar K, Thomas SL, Edmundson C, Choi YH, Beddows S, Soldan K. The impact of the national HPV vaccination program in England using the bivalent HPV vaccine: surveillance of type-specific HPV in young females, 2010–2016. J Infect Dis. 2018;218:911–21. doi:10.1093/infdis/jiy249.
  • Bruni L, Diaz M, Barrionuevo-Rosas L, Herrero R, Bray F, Bosch FX, de Sanjosé S, Castellsagué X. Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. Lancet Glob Health. 2016;4:e453–463. doi:10.1016/S2214-109X(16)30099-7.
  • Huang Y, Chen C, Wang L, Wu H, Chen T, Zhang L. HPV vaccine hesitancy and influencing factors among University students in China: a cross-sectional survey based on the 3Cs model. Int J Environ Res Public Health. 2022;19:14025. doi:10.3390/ijerph192114025.
  • Kurosawa M, Sekine M, Yamaguchi M, Kudo R, Hanley SJB, Hara M, Adachi S, Ueda Y, Miyagi E, Ikeda S, et al. Long-term effectiveness of HPV vaccination against HPV infection in young Japanese women: real-world data. Cancer Sci. 2022;113:1435–40. doi:10.1111/cas.15282.
  • Markowitz LE, Naleway AL, Klein NP, Lewis RM, Crane B, Querec TD, Hsiao A, Aukes L, Timbol J, Weinmann S, et al. Human papillomavirus vaccine effectiveness against HPV infection: evaluation of one, two, and three doses. J Infect Dis. 2020;221:910–8. doi:10.1093/infdis/jiz555.
  • Xie Y, Su L-Y, Wang F, Tang H-Y, Yang Q-G, Liu YJ. Awareness regarding and vaccines acceptability of human papillomavirus among parents of middle school students in Zunyi, Southwest China. Hum Vaccines Immunother. 2021;17:4406–11. doi:10.1080/21645515.2021.1951931.
  • Ma Y, Wang C, Liu F, Lian G, Li S, He Q, Li T. Human papillomavirus vaccination coverage and knowledge, perceptions and influencing factors among university students in Guangzhou, China. Hum Vaccines Immunother. 2021;17:3603–12. doi:10.1080/21645515.2021.1927411.
  • Burger EA, Portnoy A, Campos NG, Sy S, Regan C, Kim JJ. Choosing the optimal HPV vaccine: the health impact and economic value of the nonavalent and bivalent HPV vaccines in 48 gavi-eligible countries. Int J Cancer. 2021;148:932–40. doi:10.1002/ijc.33233.
  • Staples JN, Wong MS, Rimel BJ. An educational intervention to improve human papilloma virus (HPV) and cervical cancer knowledge among African American college students. Gynecol Oncol. 2018;149:101–5. doi:10.1016/j.ygyno.2017.10.015.